Dr. Crafton is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
4815 Liberty Ave
GR30
Bloomfield, PA 15224Phone+1 412-578-1116- Is this information wrong?
Education & Training
Ohio State University/Mt Carmel HospitalFellowship, Gynecologic Oncology, 2015 - 2018- Ohio State University/Mt Carmel HospitalResidency, Obstetrics and Gynecology, 2011 - 2015
University of AkronMaster's Certificate, Women's Studies, 2008 - 2011
Northeast Ohio Medical UniversityClass of 2011- Youngstown State UniversityB.S., Combined Science, 2004 - 2007
Certifications & Licensure
OH State Medical License 2011 - 2025
PA State Medical License 2018 - 2024- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Gold Humanism Honor Society NEOMED, 2011
- Inductee Alpha Omega Alpha Honor Medical Society, 2011
Clinical Trials
- Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2021 Sep 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- A review of the state of cervical cancer: updates from prevention to recurrent disease.Sarah M Crafton, Puja S Venkat, Ritu Salani> ;Current Opinion in Obstetrics & Gynecology. 2024 Feb 1
- 1 citationsA phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chem...Robert W Holloway, Premal Thaker, Alberto A Mendivil, Sarfraz Ahmad, Ahmed N Al-Niaimi, James Barter, Tiffany Beck, Setsuko K Chambers, Robert L Coleman, Sarah M Craft...> ;International Journal of Gynecological Cancer. 2023 Sep 4
- 7 citationsOptimal overall treatment time for adjuvant therapy for women with completely resected, node-positive vulvar cancer.Sarah Ashmore, Sarah M. Crafton, Eirwen M. Miller, T. Krivak, Scott Glaser, Solomiya R. Teterichko, Paniti Sukumvanich, Akila N. Viswanathan, Sushil Beriwal, Zachary D...> ;Gynecologic Oncology. 2021 Jan 23
- Join now to see all
Press Mentions
Dr. Crafton on Considerations for Secondary Cytoreduction in Ovarian CancerFebruary 18th, 2020- Dr. Crafton on the Impact of PARP Inhibitors in Recurrent Ovarian CancerDecember 20th, 2019
The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
Professional Memberships
- Fellow
- Society of Gynecologic OncologyMember
External Links
- Allegheny Health Networkhttps://doctors.ahn.org/Sarah-Crafton
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
